Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 12/20 | 0.71 |
| ▸ | DPP9 | Q86TI2 | 10/20 | 0.71 |
| ▸ | DPP8 | Q6V1X1 | 9/20 | 0.71 |
| ▸ | DPP4 | P27487 | 4/20 | 0.50 |
| ▸ | ABHD6 | Q9BV23 | 2/20 | 0.49 |
| ▸ | NAMPT | P43490 | 3/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31432787 | 1.00 | DPP7 (0.71) | DPP7DPP9DPP8DPP4ABHD6 | |
| SCHEMBL31432812 | 1.00 | DPP7 (0.71) | DPP7DPP9DPP8DPP4ABHD6 | |
| SCHEMBL31432865 | 0.87 | DPP7 (0.69) | DPP7DPP9DPP8DPP4ABHD6 | |
| SCHEMBL25258146 | 0.84 | DPP7 (0.66) | DPP7DPP9DPP8DPP4ABHD6 | |
| SCHEMBL12571109 | 0.81 | DPP8 (0.67) | DPP7DPP9DPP8DPP4NAMPT | |
| SCHEMBL31432958 | 0.81 | DPP8 (0.62) | DPP7DPP9DPP8DPP4ABHD6 | |
| SCHEMBL31432838 | 0.81 | DPP8 (0.62) | DPP7DPP9DPP8DPP4ABHD6 | |
| SCHEMBL31463256 | 0.77 | DPP7 (0.57) | DPP7DPP9DPP8DPP4ABHD6 | |
| SCHEMBL16101941 | 0.76 | NOTUM (0.60) | DPP7DPP9DPP8ABHD6NAMPT | |
| SCHEMBL20612064 | 0.75 | DPP8 (0.54) | DPP7DPP9DPP8ABHD6NAMPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025088073-A1 | HETEROCYCLIC COMPOUNDS AS BLT2 AGONISTS AND THEIR MEDICAL USE | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-05-01 | — | — | WO | disclosed |